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PERSPECTIVES OF NOVEL POLY(D,L-LACTIDE-CO-
 
GLYCOLIDE)/HYDROXYAPATITE
 
CORE-SHELL
 
NANOPARTICLES AS CARRIERS OF ANTIBIOTICS
PLGA/HAp core-shells gave
 
satisfied outcome 
during their interaction with human-like MRC-5 and 
L929 mouse fibroblast cells showing high level of 
compatibility and bioactivity of material which
 
 
opened interesting field for the future in vivo
 
research. Concerning
 
that biodegradable PLGA
 
 
shell is able to control process of drug release and 
that osteoconductive HAp core is able to promote 
bone reparation process, PLGA/HAp
 
material
 
 
shows
 
promising properties for delivery of
 
 
antibiotics.
PLGA/HAp particles with loaded antibiotic 
showed morphology of nanostructured core-shells
 
with planar organization. These structures were
 
 
able to provide controlled release of the drug
 
 
without initial burst effect. During the process of in 
vitro degradation, sphere-like morphology turned
 
 
into the porous.
 
Surface properties were 
continuously changed along degradation process 
showing increased wettability and surface area 
after 30 days of agging in PBS medium.
 
 
Characteristics of the material’s surface  provided 
attachment of MRC-5 and L929 cells onto the
 
 
material. Histological analyses showed absence of 
the changes in the shape and texture of vital cells 
and they had high affinity for interaction with
 
 
material. According to the tests
 
based on the 
mitochondrial activity (MTT) and compactness of 
the cells’
 
membrane (DET), after cells interactions 
with PLGA/HAp with different contents of antibiotic 
during first 24h, high percents of survival were
 
 
obtained. Agar test showed no detectable zone of 
decoloration around the samples and no
 
 
observable signs of cell lysis indicating 0/0 cell 
response meaning absence or very low cytotoxicity 
effect .
AIM
Local drug delivery for the treatment of infectious bone tissue diseases is a high-importance topic in the field of biomedicine for a last two decades. In 
general, some of the main problems related to controlled drug delivery of antibiotics are: (i) high initial burst effect with toxic outcome and (ii) low concentration of 
released drug during extended period of time with possibility for development of resistant spaces. There are some examples suggesting that core-shell particles 
applied as carriers of drug are able to provide high control over the process of drug release and to prevent burst effect.
In this work, properties of PLGA/HAp composite, loaded with clindamycin in the form of active base and proactive
 
phosphate, were
 
analyzed. The main 
goals were:
 
(i) investigation of the surface properties of material obtained during in vitro degradation, (i) analysis of material’s
 
cytocompatibility with fibroblast cells 
and (iii) estimation  of the correlation between material’s surface properties and cellular response.
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EXPERIMENTAL PART
Antibiotic
(wt. %)
MTT 
 
(survival 
 
%)
DET 
 
(survival 
 
%)
Agar test
0 92.9±1.2 93.6±2.3 0/0
1 80.9±0.3 91.2±5.0 0/0
5 74.1±2.9 89.6±2.8 0/0
10 68.8±1.4 85.3±2.4 0/0
Degradation 
time (days)
Contact 
 
angle (0)
0 89
5 56
9 40
13 52
18 57
24 58
30 64
SURFACE PROPERTIES
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Degradation medium: PBS
Temperature: 37 0C
Replacement of the buffer: 
every day
pH value: 7.4
Shaking rate: 60 rpm
DRUG RELEASE
CYTOTOXCISITY
Degradation 
time (days)
Surface area 
(m2/g)
0 8.9
5 0.3
7 No signal
13 No signal
18 No signal
21 26.6
30 70.9
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MORPHOLOGY and STRUCTURE
